You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

SCHERING Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SCHERING, and what generic and branded alternatives to SCHERING drugs are available?

SCHERING has one hundred and one approved drugs.



Summary for SCHERING
US Patents:0
Tradenames:63
Ingredients:55
NDAs:101

Drugs and US Patents for SCHERING

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering Plough DRIXORAL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 013483-003 Sep 13, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Schering NORMOZIDE hydrochlorothiazide; labetalol hydrochloride TABLET;ORAL 019046-003 Apr 6, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up
Schering METIMYD prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 010210-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
Schering ESTINYL ethinyl estradiol TABLET;ORAL 005292-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for SCHERING

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering REBETOL ribavirin SOLUTION;ORAL 021546-001 Jul 29, 2003 6,461,605*PED ⤷  Sign Up
Schering Plough LOTRIMIN clotrimazole CREAM;TOPICAL 017619-001 Approved Prior to Jan 1, 1982 3,705,172 ⤷  Sign Up
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-001 Jun 13, 1986 4,863,743 ⤷  Sign Up
Schering NOXAFIL posaconazole SUSPENSION;ORAL 022003-001 Sep 15, 2006 8,263,600 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for SCHERING drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Oral Suspension 40 mg/mL ➤ Subscribe 2011-02-28
➤ Subscribe Injection 18 mg/mL, 16.7 mL vials ➤ Subscribe 2015-11-24
➤ Subscribe Delayed-release Tablets 100 mg ➤ Subscribe 2014-06-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.